Anti-cancer drug delivery: developing a predictive in silico model to improve chemotherapy drug delivery

Dr M.E. Hubbard's profile is coming soon

Career overview

Professor Pam Jones is a prominent academic in the field of biomedical research, currently serving as the Director of the Leeds Institute of Medical Research at St James''s since June 2018. She has held the position of Professor of Biomedical Research since 2012 and previously served as the Pro-Dean for Research & Innovation for the Faculty of Medicine and Health. Her prior roles include Director of St James’s Campus Infrastructure and Facilities from 2011 to 2014, and Deputy Director of the Biomedical & Health Research Centre from 2009 to 2014. Before joining the University of Leeds, Professor Jones held postdoctoral research positions in the Department of Cell Biology at the Biocentre and the Friedrich Miescher Institute in Basel, Switzerland, as well as a Senior Scientist role at Regeneron Pharmaceuticals in Tarrytown, NY, USA. Professor Jones has a strong academic background with a BA (Hons) in Biochemistry, an MA, and a D.Phil. from the University of Oxford. Her research expertise encompasses molecular biology, angiogenesis, and cell biology, with a focus on the role of endothelial cells in vascular function. She has made significant contributions to the field, including the cloning of key cellular signalling molecules and holds over 120 GenBank entries along with being an inventor on 10 US and over 50 worldwide patents. Professor Jones is a Fellow of the Higher Education Academy and is affiliated with the British Microcirculation and Vascular Biology Society and the European Microcirculation Society.

Research interests

Professor Jones''s research focuses on molecular biology, specifically in the areas of angiogenesis and the role of endothelial cells in vascular function. She has an extensive background in cloning key cellular signalling molecules, including PKB (Akt), neurotrophin 4/5, noggin, various forms of EGFR, Trk and Tie receptor kinases, and all members of the angiopoietin family. Professor Jones is an inventor on 10 US and over 50 worldwide patents and has over 120 GenBank entries. Her work has contributed significantly to understanding the mechanisms of angiogenesis and its implications in various diseases, particularly cancer.